OTCMCMPUY
Market cap1.17bUSD
Dec 09, Last price
23.10USD
Name
CompuGroup Medical SE & Co KgaA
Chart & Performance
Profile
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides administrative and billing-related software applications for pharmacies. Its software solution provides information and decision support to manage various aspects of supply chain for medication. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals, rehabilitation centers, social services, multi-location hospital networks and regional care organizations, and medical laboratories. The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases for healthcare service providers, as well as digital healthcare stock, consumer portals, and mobile apps. This segment also offers security solutions for healthcare providers. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical SE and changed its name to CompuGroup Medical SE & Co. KGaA in June 2020. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 1,187,663 5.13% | 1,129,739 10.18% | 1,025,322 22.46% | |||||||
Cost of revenue | 246,616 | 322,750 | 323,974 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 941,047 | 806,989 | 701,348 | |||||||
NOPBT Margin | 79.24% | 71.43% | 68.40% | |||||||
Operating Taxes | 25,800 | 32,699 | 28,842 | |||||||
Tax Rate | 2.74% | 4.05% | 4.11% | |||||||
NOPAT | 915,247 | 774,290 | 672,506 | |||||||
Net income | 45,916 -37.45% | 73,411 6.44% | 68,970 -5.77% | |||||||
Dividends | (26,117) | (26,117) | (26,367) | |||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 305,361 | 147,841 | ||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 25,858 | 53,301 | 115,681 | |||||||
Long-term debt | 797,519 | 786,509 | 682,842 | |||||||
Deferred revenue | 15,529 | 9,307 | ||||||||
Other long-term liabilities | 142,760 | 38,237 | 44,927 | |||||||
Net debt | 726,116 | 738,802 | 675,482 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 179,528 | 145,027 | 165,274 | |||||||
CAPEX | (18,973) | (81,038) | (77,495) | |||||||
Cash from investing activities | (124,327) | (145,414) | (163,976) | |||||||
Cash from financing activities | (80,687) | (16,359) | 30,153 | |||||||
FCF | 884,856 | 763,780 | 650,797 | |||||||
Balance | ||||||||||
Cash | 64,557 | 91,013 | 107,628 | |||||||
Long term investments | 32,704 | 9,995 | 15,413 | |||||||
Excess cash | 37,878 | 44,521 | 71,775 | |||||||
Stockholders' equity | 55,329 | 779,028 | 711,080 | |||||||
Invested Capital | 1,541,096 | 1,416,498 | 1,303,476 | |||||||
ROIC | 61.89% | 56.93% | 54.18% | |||||||
ROCE | 59.60% | 51.43% | 47.53% | |||||||
EV | ||||||||||
Common stock shares outstanding | 52,455 | 52,289 | 52,971 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 1,056,845 | 919,310 | 812,061 | |||||||
EV/EBITDA | ||||||||||
Interest | 24,318 | 9,118 | 5,399 | |||||||
Interest/NOPBT | 2.58% | 1.13% | 0.77% |